Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

A UConn clinical trial confirms that eating walnuts promotes colonic health and may help prevent cancer. New research ...

The top health system CIOs have been using innovative digital solutions to address some of healthcare’s most pressing challenges. Several health systems were recently named winners of CIO 100 Awards ...

While recent data suggest that some hospital and health system finances have experienced modest stabilization from historic ...

Duke Health has recently implemented Microsoft Copilot and an artificial intelligence tool for ambient listening to ensure ...

The healthcare landscape as we knew it, like several other industries, has been fundamentally transformed by artificial ...

Developed through the integration of Inocras's comprehensive CancerVision™ WGS cancer profiling platform and Ultima Genomics' ppmSeq™ technology, MRDVision delivers a breakthrough approach for ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration ...

Most systems are relying on reducing clinical burnout and other softer metrics as a way to justify the investment in ambient ...

Zymeworks' financial stability is evident with $76.3 million in revenue in 2024 and a cash runway extending through late 2027 ...